Tertiary hyperparathyroidism in kidney transplant recipients: Characteristics of patients selected for different treatment strategies

Transplantation

Volumn 94, Issue 1, 2012, Pages 70-76

  Yang, Rachel L ^a   Freeman, Kate ^a   Reinke, Caroline E ^a   Fraker, Douglas L ^a   Karakousis, Giorgos C ^a   Kelz, Rachel R ^a   Doyle, Alden M ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Calcimimetic agents; Hyperparathyroidism; Kidney transplantation; Parathyroidectomy

Indexed keywords

CALCIUM; CINACALCET; CREATININE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL OBSERVATION; COHORT ANALYSIS; CREATININE BLOOD LEVEL; ENDORSE OBSERVATION; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERCALCEMIA; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HYPERPARATHYROIDISM;

ADULT; AGED; CALCIUM; COHORT STUDIES; CREATININE; FEMALE; HUMANS; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROIDECTOMY; RETROSPECTIVE STUDIES;

EID: 84863716971     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182530699     Document Type: Article

References (24)

1. Memmos D, Williams G, Eastwood J, et al. The role of parathyroidectomy in the management of hyperparathyroidism in patients on maintenance haemodialysis and after renal transplantation. Nephron 1982; 30: 143.
2. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002; 13: 551.
3. Schlosser K, Zielke A, Rothmund M. Medical and surgical treatment for secondary and tertiary hyperparathyroidism. Scand J Surg 2004; 93: 288.
4. Heaf J, Tvedegaard E, Kanstrup IL, et al. Hyperparathyroidism and long-termbone loss after renal transplantation. Clin Transplant 2003; 17: 268.
5. Julian BA, Quarles LD, Niemann KM. Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis 1992; 19: 99.
6. Boom H, Mallat MJ, De Fijter JW, et al. Calcium levels as a risk factor for delayed graft function. Transplantation 2004; 77: 868.
7. Ozdemir FN, Afsar B, Akgul A, et al. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 2006; 38: 480.
8. Schwarz A, Rustien G, Merkel S, et al. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 2007; 22: 584.
9. Garcia A, Mazuecos A, Garcia T, et al. Effect of parathyroidectomy on renal graft function. Transplant Proc 2005; 37: 1459.
10. Rostaing L, Moreau-Gaudry X, Baron E, et al. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin Nephrol 1997; 47: 248.
11. Evenepoel P, Claes K, Kuypers DR, et al. Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant 2007; 22: 1730.
12. Schmid T, Müller P, Spelsberg F. Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome. Nephrol Dial Transplant 1997, 12: 2393.
13. Park JH, Kang SW, Jeong JJ, et al. Surgical treatment of tertiary hyperparathyroidism after renal transplantation: a 31-year experience in a single institution. Endocr J 2011; 58: 827.
14. Triponez F, Clark OH, Vanrenthergem Y, et al. Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 2008; 248: 18.
15. Evenepoel, P, Claes, K, Kuypers, D, et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004; 19: 1281.
16. Milas M, Weber CJ. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery 2004; 136: 1252.
17. Drakopoulos S, Koukoulaki M, Apostolou T, et al. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg 2009; 198: 178.
18. Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991; 15: 745.
19. Gasparri G, Camandona M, Abbona GC, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 2001; 233: 65.
20. Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1315.
21. Kruse AE, Eisenberger U, Frey FJ, et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005; 20: 1311.
22. Lewin E, Olgaard K. Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation. Nephrol Dial Transplant 2006; 21: 1766.
23. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
24. Stevens LA, Coresh J,GreeneT, et al.Assessing kidney functionVmeasured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473.